# Marten Transport Ltd: financial statements, quarterly

MRTN · Nasdaq · CIK 799167 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mrtn.md) · [Financials](/companies/mrtn/financials.md) · [Filings](/companies/mrtn/filings.md) · [Insiders](/companies/mrtn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mrtn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [280](/filings/0001437749-24-034042.md) | [268 d](/filings/0001437749-24-005794.md) | [250](/filings/0001437749-25-015634.md) | [246](/filings/0001437749-24-025273.md) | [237](/filings/0001437749-24-034042.md) | [230 d](/filings/0001437749-26-005971.md) | [223](/filings/0001437749-25-015634.md) | [230](/filings/0001437749-26-026046.md) | [220](/filings/0001437749-25-033702.md) | [210 d](/filings/0001437749-26-005971.md) | [204](/filings/0001437749-26-015748.md) | [224](/filings/0001437749-26-026046.md) |
| Operating income | $m | [17.2](/filings/0001437749-24-034042.md) | [15.7 d](/filings/0001437749-26-005971.md) | [12.3](/filings/0001437749-25-015634.md) | [10.0](/filings/0001437749-25-025548.md) | [4.3](/filings/0001437749-25-033702.md) | [6.7 d](/filings/0001437749-26-005971.md) | [5.9](/filings/0001437749-26-015748.md) | [9.7](/filings/0001437749-26-026046.md) | [2.7](/filings/0001437749-25-033702.md) | [4.6 d](/filings/0001437749-26-005971.md) | [1.6](/filings/0001437749-26-015748.md) | [6.9](/filings/0001437749-26-026046.md) |
| Income tax | $m | [4.6](/filings/0001437749-24-034042.md) | [4.1 d](/filings/0001437749-26-005971.md) | [3.4](/filings/0001437749-25-015634.md) | [3.1](/filings/0001437749-25-025548.md) | [1.4](/filings/0001437749-25-033702.md) | [1.5 d](/filings/0001437749-26-005971.md) | [1.9](/filings/0001437749-26-015748.md) | [3.0](/filings/0001437749-26-026046.md) | [0.7](/filings/0001437749-25-033702.md) | [1.4 d](/filings/0001437749-26-005971.md) | [0.7](/filings/0001437749-26-015748.md) | [2.3](/filings/0001437749-26-026046.md) |
| Net income | $m | [13.6](/filings/0001437749-24-034042.md) | [12.4 d](/filings/0001437749-26-005971.md) | [9.6](/filings/0001437749-25-033702.md) | [7.9](/filings/0001437749-25-033702.md) | [3.8](/filings/0001437749-25-033702.md) | [5.6 d](/filings/0001437749-26-005971.md) | [4.3](/filings/0001437749-26-026046.md) | [7.2](/filings/0001437749-26-026046.md) | [2.2](/filings/0001437749-25-033702.md) | [3.7 d](/filings/0001437749-26-005971.md) | [1.4](/filings/0001437749-26-026046.md) | [5.3](/filings/0001437749-26-026046.md) |
| Diluted EPS | $ per share | [0.17](/filings/0001437749-24-034042.md) | not reported | [0.12](/filings/0001437749-25-015634.md) | [0.10](/filings/0001437749-25-025548.md) | [0.05](/filings/0001437749-25-033702.md) | not reported | [0.05](/filings/0001437749-26-015748.md) | [0.09](/filings/0001437749-26-026046.md) | [0.03](/filings/0001437749-25-033702.md) | not reported | [0.02](/filings/0001437749-26-015748.md) | [0.07](/filings/0001437749-26-026046.md) |
| Basic EPS | $ per share | [0.17](/filings/0001437749-24-034042.md) | not reported | [0.12](/filings/0001437749-25-015634.md) | [0.10](/filings/0001437749-25-025548.md) | [0.05](/filings/0001437749-25-033702.md) | not reported | [0.05](/filings/0001437749-26-015748.md) | [0.09](/filings/0001437749-26-026046.md) | [0.03](/filings/0001437749-25-033702.md) | not reported | [0.02](/filings/0001437749-26-015748.md) | [0.07](/filings/0001437749-26-026046.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [68.1](/filings/0001437749-23-030762.md) | [53.2](/filings/0001437749-26-005971.md) | [73.7](/filings/0001437749-24-015446.md) | [77.2](/filings/0001437749-24-025273.md) | [43.0](/filings/0001437749-25-033702.md) | [17.3](/filings/0001437749-26-005971.md) | [39.9](/filings/0001437749-26-015748.md) | [35.1](/filings/0001437749-26-026046.md) | [49.5](/filings/0001437749-25-033702.md) | [43.3](/filings/0001437749-26-026046.md) | [69.8](/filings/0001437749-26-015748.md) | [104](/filings/0001437749-26-026046.md) |
| Current assets | $m | [225](/filings/0001437749-23-030762.md) | [197](/filings/0001437749-25-005570.md) | [214](/filings/0001437749-24-015446.md) | [220](/filings/0001437749-24-025273.md) | [170](/filings/0001437749-24-034042.md) | [139](/filings/0001437749-26-005971.md) | [163](/filings/0001437749-25-015634.md) | [156](/filings/0001437749-25-025548.md) | [176](/filings/0001437749-25-033702.md) | [172](/filings/0001437749-26-026046.md) | [196](/filings/0001437749-26-015748.md) | [238](/filings/0001437749-26-026046.md) |
| Total assets | $m | [997](/filings/0001437749-23-030762.md) | [990](/filings/0001437749-25-005570.md) | [993](/filings/0001437749-24-015446.md) | [1,010](/filings/0001437749-24-025273.md) | [1,000](/filings/0001437749-24-034042.md) | [969](/filings/0001437749-26-005971.md) | [983](/filings/0001437749-25-015634.md) | [992](/filings/0001437749-25-025548.md) | [976](/filings/0001437749-25-033702.md) | [950](/filings/0001437749-26-026046.md) | [947](/filings/0001437749-26-015748.md) | [955](/filings/0001437749-26-026046.md) |
| Current liabilities | $m | [122](/filings/0001437749-23-030762.md) | [110](/filings/0001437749-25-005570.md) | [111](/filings/0001437749-24-015446.md) | [119](/filings/0001437749-24-025273.md) | [117](/filings/0001437749-24-034042.md) | [93.5](/filings/0001437749-26-005971.md) | [110](/filings/0001437749-25-015634.md) | [117](/filings/0001437749-25-025548.md) | [116](/filings/0001437749-25-033702.md) | [92.2](/filings/0001437749-26-026046.md) | [94.3](/filings/0001437749-26-015748.md) | [95.0](/filings/0001437749-26-026046.md) |
| Total liabilities | $m | [248](/filings/0001437749-23-030762.md) | [233](/filings/0001437749-25-005570.md) | [231](/filings/0001437749-24-015446.md) | [243](/filings/0001437749-24-025273.md) | [234](/filings/0001437749-24-034042.md) | [201](/filings/0001437749-26-005971.md) | [216](/filings/0001437749-25-015634.md) | [221](/filings/0001437749-25-025548.md) | [207](/filings/0001437749-25-033702.md) | [182](/filings/0001437749-26-026046.md) | [183](/filings/0001437749-26-015748.md) | [190](/filings/0001437749-26-026046.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [749](/filings/0001437749-24-034042.md) | [757](/filings/0001437749-26-005971.md) | [762](/filings/0001437749-25-033702.md) | [767](/filings/0001437749-25-033702.md) | [766](/filings/0001437749-25-033702.md) | [768](/filings/0001437749-26-026046.md) | [768](/filings/0001437749-26-026046.md) | [771](/filings/0001437749-26-026046.md) | [768](/filings/0001437749-25-033702.md) | [768](/filings/0001437749-26-026046.md) | [764](/filings/0001437749-26-026046.md) | [766](/filings/0001437749-26-026046.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [28.1 d](/filings/0001437749-24-034042.md) | [38.0 d](/filings/0001437749-26-005971.md) | [45.7](/filings/0001437749-25-015634.md) | [35.8 d](/filings/0001437749-25-025548.md) | [29.5 d](/filings/0001437749-25-033702.md) | [23.8 d](/filings/0001437749-26-005971.md) | [36.2](/filings/0001437749-26-015748.md) | [33.2 d](/filings/0001437749-26-026046.md) | [18.5 d](/filings/0001437749-25-033702.md) | [5.6 d](/filings/0001437749-26-005971.md) | [33.0](/filings/0001437749-26-015748.md) | [27.7 d](/filings/0001437749-26-026046.md) |
| Dividends paid | $m | [4.9 d](/filings/0001437749-24-034042.md) | [4.9 d](/filings/0001437749-26-005971.md) | [4.9](/filings/0001437749-25-015634.md) | [4.9 d](/filings/0001437749-25-025548.md) | [4.9 d](/filings/0001437749-25-033702.md) | [4.9 d](/filings/0001437749-26-005971.md) | [4.9](/filings/0001437749-26-015748.md) | [4.9 d](/filings/0001437749-26-026046.md) | [4.9 d](/filings/0001437749-25-033702.md) | [4.9 d](/filings/0001437749-26-005971.md) | [4.9](/filings/0001437749-26-015748.md) | [4.9 d](/filings/0001437749-26-026046.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-23-030762.md) | [0.0 d](/filings/0001437749-25-005570.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [81.3](/filings/0001437749-23-030762.md) | [81.4](/filings/0001437749-24-015446.md) | [81.4](/filings/0001437749-24-025273.md) | [81.5](/filings/0001437749-24-034042.md) | [81.4](/filings/0001437749-25-015634.md) | [81.4](/filings/0001437749-25-025548.md) | [81.5](/filings/0001437749-25-033702.md) | [81.5](/filings/0001437749-26-015748.md) | [81.5](/filings/0001437749-26-026046.md) | [81.5](/filings/0001437749-25-033702.md) | [81.6](/filings/0001437749-26-015748.md) | [81.6](/filings/0001437749-26-026046.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 81,661,669 at 2026-07-28, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026046.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.